Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemiaSara Silbert, Marlie R. M. Provost, Constance M. Yuan et al.|Blood|2025Cited by 33
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoringÁgueda Molinos-Quintana, Josè Antonio Pérez-Simón, Anna Alonso‐Saladrigues et al.|Frontiers in Immunology|2024Cited by 21
Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LSSara Silbert, Elad Jacoby, Cynthia Harrison et al.|Blood|2023Cited by 5
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoringÁgueda Molinos-Quintana, Josè Antonio Pérez-Simón, Anna Alonso‐Saladrigues et al.|Frontiers in Immunology|2024Cited by 1